March 2025 | Investor Webinar

CEO Dr Paul Gavin hosted an investor webinar to discuss our milestone licensing and development agreement with Sandoz.

His presentation provided a detailed overview of the agreement, including the substantial commercial opportunity associated with being the first pharmaceutical company to develop an over-the-counter CBD product for insomnia, and next steps as we progress our pivotal Phase III clinical trial.

Watch the replay: